The sequential schedule for poliovirus immunization: factors associated with its adoption by primary care providers by Ellis, Melissa Sharyn
Yale University
EliScholar – A Digital Platform for Scholarly Publishing at Yale
Yale Medicine Thesis Digital Library School of Medicine
2000
The sequential schedule for poliovirus
immunization: factors associated with its adoption
by primary care providers
Melissa Sharyn Ellis
Yale University
Follow this and additional works at: http://elischolar.library.yale.edu/ymtdl
Part of the Medicine and Health Sciences Commons
This Open Access Thesis is brought to you for free and open access by the School of Medicine at EliScholar – A Digital Platform for Scholarly
Publishing at Yale. It has been accepted for inclusion in Yale Medicine Thesis Digital Library by an authorized administrator of EliScholar – A Digital
Platform for Scholarly Publishing at Yale. For more information, please contact elischolar@yale.edu.
Recommended Citation
Ellis, Melissa Sharyn, "The sequential schedule for poliovirus immunization: factors associated with its adoption by primary care







Permission to photocopy or microfilm processing 
of this thesis for the purpose of individual 
scholarly consultation or reference is hereby 
granted by the author. This permission is not to be 
interpreted as affecting publication of this work or 
otherwise placing it in the public domain, and the 
author reserves all rights of ownership guaranteed 
under common law protection of unpublished 
manuscripts. 
Signature of Author 
h\arc-\A 14, 2.0QC) 
Date 
Digitized by the Internet Archive 
in 2017 with funding from 




The Sequential Schedule for Poliovirus Immunization: 
Factors Associated with Its Adoption by Primary Care Providers 
A Thesis Submitted to the 
Yale University School of Medicine 
in Partial Fulfillment of the Requirements for the 
Degree of Doctor of Medicine 
by 
Melissa Sharyn Ellis 
2000 
Yfltf MFPinsi uRPApy 





THE SEQUENTIAL SCHEDULE FOR POLIOVIRUS IMMUNIZATION: FACTORS ASSOCIATED 
WITH ITS ADOPTION BY PRIMARY CARE PROVIDERS 
Melissa S. Ellis, Philip LaRussa, Sally Findley, and Matilde Irigoyen. Department of Pediatrics, Columbia 
University, New York, NY. (Sponsored by Eugene Shapiro, Department of Pediatrics, Yale University 
School of Medicine, New Haven, CT). 
Background and objectives: In January 1997 the Advisory Committee on Immunization Practices (ACIP) 
recommended switching from, a schedule consisting solely of oral polio vaccine to a sequential one 
consisting of both an inactivated, injectable vaccine and an oral vaccine. The objectives of this project 
were to gain a better understanding of how providers learn about changes in immunization policy and to 
identify factors that were important to them in deciding whether to adopt the sequential schedule. 
Methods: Providers in Northern Manhattan were surveyed between July and August 1997. Data were 
collected on the professional qualifications of the providers, their practice demographics, providers’ 
preferences for information sources, and their current polio immunization practices. 
Results: 24% of providers had already adopted the sequential schedule, 40% were planning to adopt it, and 
36% were not planning to adopt it. Compared with those who had no plans to switch, providers who either 
had already switched or planned to switch were more likely to be members of the American Academy of 
Pediatrics (AAP) (64.9% vs. 33.3%, p=0.021), to have a faculty appointment (75.7% vs. 42.9%, p=0.012), 
and to prefer using MEDLINE (56.8% vs. 28.6%, p=0.039) or the “Red Book” (51.4% vs. 23.8%, p=0.041) 
as sources of vaccination information. All providers identified similar factors that were important in their 
vaccination decision making: compliance with ACIP, medical issues, personal judgment, and parental 
concerns were considered more important than legal issues, logistic issues, and cost. When asked what 
would make them switch to the sequential schedule, providers who were planning to adopt the sequential 
schedule most commonly cited stronger recommendations by ACIP while those not planning to adopt cited 
a legal mandate by the New York City Department of Health. 
Conclusions: Providers who were not planning to adopt the sequential schedule were less likely to be 
affiliated with an academic institution, to be AAP members, and to prefer the use of MEDLINE or the “Red 
Book” for vaccination information. Our study identified a group of providers that would benefit from more 
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In January of 1997, the Advisory Committee on Immunization Practices (ACIP) 
recommended a change in the polio immunization schedule from a four-dose schedule of 
orally-administered live-attenuated trivalent polio vaccine (OPV) to a sequential one 
consisting of an enhanced potency inactivated polio vaccine (elPV) at 2 and 4 months 
followed by OPV at 12-18 months and 4-6 years.1 The revised recommendations also 
stated that an all-OPV or an all-elPV schedule met current standards of care for routine 
childhood vaccination. While all three vaccination schedules were acceptable in offering 
protection against paralytic polio, the sequential elPV/OPV schedule was preferable 
because it could potentially reduce the number of cases of vaccine-associated paralytic 
polio (VAPP) by fifty percent1 and still provide acceptable levels of intestinal immunity. 
These recommendations were intended to aid in the transition towards the goal of 
exclusive use of elPV during the subsequent three to five years. 
In 1997, approximately five months after the recommendations for the sequential 
schedule were published, we conducted a survey of pediatricians and other health care 
providers in Northern Manhattan to assess their familiarity with the new 
recommendations, their opinions about the changes, and their future intentions regarding 
polio vaccination scheduling. The objectives of this project were (1) to gain a better 
understanding of how health care providers learn about changes in immunization policy 
(i.e., preferred sources of information) and (2) to identify factors that are important to 
them in deciding whether to adopt the new recommendations. The goal of this project 
was to gain insight into what motivates providers to implement changes in their current 
vaccination practices. 

Many studies have attempted to answer the question as to what motivates 
physicians to change the way they practice medicine. One analysis in the literature 
classified the methods of changing physicians’ practices into six general categories: 
education, feedback, participation by physicians in efforts to bring about change, 
administrative rules, financial incentives, and financial penalties. While each method 
has been shown to be effective on its own, interventions that rely on more than one 
method generally have had the most success. Based on the categorization presented 
above, clinical practice guidelines pertaining to vaccination issues and vaccine 
recommendations by professional organizations and committees, such as ACLP, are 
considered forms of education. They are designed to inform providers about new 
vaccines, new practices and/or those that meet current standards of care. Little is known 
about how providers decide to implement changes in their practice methods once they 
become aware of new guidelines. Overall, it has been found that clinical practice 
guidelines have been remarkably unsuccessful in influencing physicians. ’ While no 
studies have investigated the efficacy of ACIP vaccination recommendations to influence 
change in physicians’ practice, given the similarities between such recommendations and 
practice guidelines, it is likely that both share the same low level of success in changing 
physicians’ behaviors. 
Various barriers to compliance have been identified to explain the lack of success 
of clinical practice guidelines among providers, including a lack of awareness of, 
agreement with, and familiarity with the guidelines; lack of outcome-expectancy (i.e., the 
expectation that a given behavior will lead to a particular consequence); inertia of 
previous practice (i.e., no motivation to change); and external barriers (e.g., perception 
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that patients fear additional injections). In this study we identified factors that providers 
consider important when deciding to change their vaccination practices and that correlate 
with increased compliance with the new recommendations for polio immunization. In 
light of the ongoing changes in polio vaccination recommendations and the certainty that 
there will be more changes in the childhood immunization schedule in the future, the 
lessons learned from this study may be utilized to develop more effective means of 
disseminating new recommendations and to identify groups that should be especially 
targeted for interventions to improve compliance with such recommendations. 
Methods 
We attempted to identify all providers in the study area with M.D. degrees who 
regularly cared for children and who administered routine childhood vaccinations in 
outpatient settings. Our study area consisted of neighborhoods north of 96th Street on the 
west side of Manhattan. We compiled a list of all providers that we could identify from a 
variety of sources including health plan directories from H.M.O.s that serve Northern 
Manhattan, the Yellow Pages, the fellowship directories of the American Academy of 
Pediatrics of New York, a list of participating providers in the Vaccines for Children 
program, and staff rolls of the New York Presbyterian, Harlem, and St. Luke's-Roosevelt 
Hospitals. 
While the majority of questionnaires were administered in person, some providers 
chose to be interviewed by telephone. In both settings, the provider had a copy of the 
questions so that he or she could follow along while the interviewer verbally 
administered the questionnaire. All answers were recorded by the interviewer. The 
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questionnaire was administered during July and August of 1997. It consisted of 46 
questions, required about 20 minutes to complete, and addressed three major issues: 
(1) providers' preferences for information sources, 
(2) awareness of and opinions about the recommended changes in the polio immunization 
schedule, 
(3) current polio immunization practices and plans for the future. 
We also gathered demographic data on the providers who completed the questionnaire. 
Part one consisted of questions of two types: open-ended questions and forced 
choice questions with the opportunity to include additional responses. Providers selected 
from a list of 21 different types of information sources (including MEDLINE and other 
online sources, paper journals, Grand Rounds, the “Red Book” [Report of the Committee 
on Infectious Diseases, American Academy of Pediatrics], printed material from 
manufacturers, etc.) for information on immunization practices and changes in 
vaccination recommendations. They were then asked in an open-ended format what their 
top three preferred sources were for vaccination information. 
In part two, providers were asked in an open-ended format if they were familiar 
with the debate about the changes in the polio immunization recommendations and what 
their opinion was about this. In part three, providers were asked in an open-ended format 
what their current vaccination schedule was, if they were planning to change their 
schedules in the future, what factors they considered when deciding on their schedule, 
and, if they had not yet switched to an elPV-containing schedule, what it would take to 
get them to do so in the future. 
Responses were stratified into two groups based on their polio immunization 
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practices: either (1) already adopted and planning to adopt or (2) not planning to adopt 
the sequential elPV/OPV schedule. The statistical significance of differences between 
proportions was assessed with the Chi-square test. Odds ratios, 95% confidence 
intervals, and Chi-square tests were performed using STATXACT (Cytel Software, 
Cambridge, Massachusetts). P values < 0.05 were considered statistically significant. 
The initial idea for this project was devised by Dr. LaRussa, Dr. Findley, and Dr. 
Irigoyen. They had already compiled a preliminary list of providers in the study area 
when I started to work on this project. I developed the questionnaire under their 
guidance, finalized the list of providers in the study area, and then contacted and 
interviewed all of the providers. The preliminary statistical analyses of the data were 
done by Dr. Findley. I then finalized the data using the STATXACT program under the 
direction of Dr. Shapiro. 
Results 
We identified 94 providers in our study area. Twenty-two of these providers did 
not take care of children or had recently moved out of the target area. Therefore, the total 
number of eligible providers for this study was 72. 
Of the 72 eligible providers, 58 (81%) agreed to complete the questionnaire. 
Providers surveyed in this study had practices located in either of two Northern 
Manhattan neighborhoods: Washington Heights/In wood, a predominantly Latino 
community, and West Harlem, a predominantly African-American community which has 
recently had an influx of both Latino and African immigrants. Both communities are 
marked by high levels of poverty and low levels of vaccination coverage. Providers 

deliver care in a variety of settings, such as private practices, community-based clinics 
run by H.M.O.s, and hospital-based clinics. 
6 
Current practice regarding polio vaccination schedule: While all of the 
providers surveyed in our study were familiar with the ACIP recommendations 
concerning the sequential schedule, 24% had already adopted the sequential schedule, 
40% were using an all-OPV schedule but were planning to adopt the sequential one, and 
36% were using an all-OPV schedule and were not planning to switch. Adoption/planned 
adoption of the sequential schedule was associated with membership in the American 
Academy of Pediatrics (AAP) (64.9% vs. 33.3%; OR=3.69; 95% CI=1.19-11.44; 
p=0.021) and faculty appointment (75.7% vs. 42.9%; OR=4.15; 95% 0=1.32-13.04; 
p=0.012). Foreign birth, foreign medical school education, board certification, post¬ 
graduate fellowship, and active teaching duty were not significantly associated with 
adoption of the sequential schedule (table 2). 
Information sources: Of the 21 possible information sources presented as 
choices in the questionnaire, physicians most commonly identified the following as their 
preferred vaccination information sources: peer-reviewed publications, MEDLINE, 
educational materials from manufacturers, recommendations from advisory committees, 
the “Red Book,”and AAP Alerts (table 3). Other information sources that were less 
commonly cited included text books, free publications, consults with other physicians, 
continuing medical education courses, and Grand Rounds. Providers who had either 
already adopted or planned to adopt the sequential schedule were more likely than those 
who were not planning to adopt the sequential schedule to have identified MEDLINE 
(56.8% vs. 28.6%; OR=3.28; 95% <21=1.04-10.35; p=0.039) and the “Red Book” (51.4% 
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vs. 23.8%; OR=3.38; 95% 0=1.02-11.14; p=0.041) as their preferred sources of 
information. There was no difference in the use of the other commonly preferred 
information sources among these two groups of providers. 
We further defined the group of providers who identified MEDLINE as their 
preferred source for vaccination information. While there was no statistically significant 
association between reported use of MEDLINE and AAP membership, MEDLINE users 
were more likely than non-users to have faculty appointments (88.9% vs. 4.9%; 
0R=11.08; 95% 0=2.74-44.76; p<0.001) and active teaching duty (26.0% vs. 0%; OR 
and 95% Cl undefined; p=0.003) (table 4). 
Important factors in decision-making: We asked providers to specify which 
factors were important in their decision making when choosing a polio immunization 
schedule (table 5). Almost all providers indicated that compliance with ACIP 
recommendations was important. While there were no significant differences in the 
frequencies of the listed factors among those who did and those who did not adopt the 
sequential schedule, medical issues (e.g., confidence in vaccine efficacy trials, risk of 
VAPP, herd immunity), personal judgment, and parental concerns were more commonly 
cited by all providers than legal issues, logistic issues (e.g., availability of staff to 
administer additional injections), and cost. 
In a separate question, providers who had already adopted and those who were 
planning to adopt the sequential schedule were asked to identify the most important 
factors that affected their decision to switch to the new schedule. The most commonly 
cited factors by all providers were (1) reduction in the risk of VAPP and (2) compliance 
with ACIP (table 6). Other, less commonly cited factors included maintenance of 
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intestinal immunity, fear of liability for VAPP, and safety issues for HTV-positive and 
immunocompromised recipients. For providers who had already adopted the sequential 
schedule, the difference between the importance of reducing the risk of VAPP (78.6%) 
compared to that of complying with ACIP recommendations (14.3%) when making their 
decision to adopt the sequential schedule was statistically significant (p<0.001). This 
difference was not statistically significant for providers who were planning to adopt the 
sequential schedule. 
Finally, providers who had not switched schedules at the time that the survey was 
administered (those planning to switch who had not done so yet and those with no plans 
to switch) were asked what it would take to get them to make the switch (table 7). Five 
motivating factors were most commonly identified: stronger recommendations by ACIP, 
legal mandate from the New York City Department of Health, availability of combination 
vaccines containing elPV to reduce the number of injections required per visit, evidence 
that elPV is more effective than OPV, and exhaustion of their current OPV supply. Other 
factors that were less commonly cited by providers included: an increase in the number of 
cases of VAPP per year, endorsement of the schedule by other physicians, use of elPV by 
the World Health Organization, and a decrease in elPV cost. Although the differences 
were not statistically significant, providers who were planning to adopt the sequential 
schedule more commonly indicated stronger recommendations by ACIP as a motivating 
factor to switch schedules (30.4% versus 14.3% of providers not planning to adopt), 
while providers not planning to adopt the sequential schedule more commonly indicated a 
legal mandate (42.9% versus 21% of providers planning to adopt). Among the listed 
factors, the only statistically significant difference between the two groups of providers 
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was in the importance of availability of a combination vaccine, which was cited by 17.4% 
of providers who were planning to switch schedules and by no providers who were not 
planning to switch (OR and 95% Cl undefined; p=0.045). 
Discussion 
Background: There has been a dramatic decrease in the number of cases of 
paralytic poliomyelitis since the introduction of IPV in 1955 and then OPV in the early 
1960’s. The annual number of cases of paralytic polio reported in the United States has 
declined from approximately 20,000 in 1952 to an average of 9 during the years of 1980- 
1991.4 The last indigenously acquired case in the United States was reported in 19795 
and the Western Hemisphere was declared to be free of indigenous wild polio virus in 
1994.6 Due to the large-scale efforts by the World Health Organization (WHO), polio 
cases reported globally have decreased by more than 80% since the mid-1980’s. ’ ’ In 
1988 the WHO resolved to eradicate poliomyelitis globally by the year 2000 and we are 
now close to realizing this goal. ’ These remarkable achievements throughout the world 
can be attributed to the almost exclusive use of OPV for routine childhood vaccination. 
The first polio vaccine to be introduced was the inactivated polio vaccine by 
Jonas Salk in 1955. It was replaced by oral live-attenuated trivalent polio vaccine in the 
early 1960s. Developed by Sabin, OPV was favored in the United States for routine 
immunization of children because of its ease of administration, expected long-lasting 
immunity, and the production of intestinal immunity. Intestinal immunity is a major 
advantage of OPV over IPV as it allows for fecal spread of the vaccine virus to 
unimmunized contacts. It also provides protection against intestinal infection with wild 
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virus thus limiting its spread to others. This has been regarded as an advantage of OPV 
over IPV for inner-city children, who historically have had low vaccination rates10 and 
are at the highest risk of acquiring wild polio from new immigrants. A new enhanced- 
potency inactivated polio vaccine (elPV) was introduced in 1988. While eEPV has been 
shown to induce higher post-vaccination serum antibody levels, it is less effective than 
OPV in preventing and limiting intestinal infection.11 In addition, the increased cost of 
elPV and its mode of delivery, namely injection, has historically made this a less popular 
choice in the United States compared with OPV. 
Despite its almost exclusive use for routine poliovirus vaccination in this country 
for many years, use of OPV is not without disadvantages. Each year approximately 8-9 
cases of VAPP are reported.1 VAPP occurs as a consequence of the reversal of 
attenuating mutations in the vaccine virus, potentially affecting recipients of OPV, 
unvaccinated contacts of the recipient, or other unvaccinated members of the community 
who are exposed to pathogenic revertant virus. While these molecular events may occur 
frequently, they occur only rarely with adverse consequences. The risk of acquiring 
VAPP is approximately 1 case per 2.4 million total doses distributed or 1 case per 
750,000 children receiving their first dose. ’ From 1980 to 1994, 133 confirmed cases 
of paralytic poliomyelitis were reported. Of these, 6 cases were imported from outside 
the US with only one occurring after 1986; 2 cases were considered indeterminate in 
origin. The remaining 125 cases (94%) (annual mean: 8 cases) were classified as 
vaccine-associated: 49 (39%) occurred among immunologically normal recipients of 
OPV, 46 (37%) among immunologically normal people who were suspected contacts of 
OPV recipients, and 30 (24%) among immunologically compromised OPV recipients or 
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suspected contacts of OPV recipients. 
In light of the progress being made towards global polio eradication and the 
ongoing risk of VAPP,14 in January 1997 the ACIP recommended a switch from an all- 
OPV schedule to a sequential eLPV-OPV schedule for routine childhood immunization. 
This recommendation was also endorsed by the American Academy of Pediatrics and the 
American Academy of Family Physicians. Although the sequential schedule was 
preferred, all-OPV or all-elPV schedules were also deemed acceptable. The logic behind 
the sequential schedule was that the use of elPV for the first 2 doses would reduce the 
incidence of VAPP by inducing sufficient serum neutralizing antibody to prevent 
invasive infection on subsequent vaccination with OPV. By keeping OPV in the 
schedule, children would still benefit from the advantages of OPV, namely intestinal 
immunity and secondary spread of the vaccine virus. It was hypothesized that a switch in 
this schedule would allow for a 50% decrease in the annual number of cases of VAPP.1 
When the new recommendations were introduced, there were concerns that a 
change in polio vaccination schedules would adversely affect vaccination rates because 
of the increased cost of eEPV and the addition of another series of injections to childhood 
vaccinations. However, studies have shown that there has been no associated decrease 
during this time in the vaccination coverage of routinely recommended immunizations 
for children.15 Based on the success of the sequential schedule and also the rapid 
progress of the global polio eradication initiative, which decreases the likelihood of 
poliovirus importation into the United States, ACEP has recommended that children 
follow an all-elPV schedule starting on January 1, 2000 in an effort to fully eliminate the 
risk of VAPP.16 

12 
Present study: At the time that our study was conducted, approximately five 
months after the introduction of the new recommendations in 1997, all of the providers 
were familiar with the ACIP recommendations. However, only 24% of providers had 
switched to the ACIP-preferred sequential schedule. Providers who were members of the 
American Academy of Pediatrics and those who had an appointment at an academic 
medical center were more likely to have adopted or to have been planning to adopt the 
sequential schedule. This finding is intriguing because the American Academy of 
Pediatrics did not favor one particular schedule but rather left the decision up to the 
provider. The AAP made it clear that each of the three poliomyelitis vaccine schedules 
(sequential efPV/OPV, all-elPV, or all-OPV) was highly effective and acceptable for 
routine vaccination. To explain the finding that AAP members or providers with faculty 
appointments at medical centers were more likely to have switched, one might 
hypothesize that these two groups of physicians were better informed of the issues 
involved by virtue of exposure to the educational efforts of the Academy and the 
academic medical centers. Conversely, perhaps this demonstrates a process of self- 
selection in that those who are affiliated with either the AAP or an academic medical 
center are well informed and more aware of current vaccination issues in general based 
on their self-education practices. 
While there are many possible hypotheses to explain the associations we found, 
one interesting idea concerns the use of educational strategies to change physicians’ 
practices. While clinical guidelines, one form of education, have been shown to be 
generally unsuccessful in changing physicians’ practices, providing such guidelines to 




of information) has shown some promise in accomplishing this goal." For example, in 
one study, the rate of cesarean sections was dramatically reduced when opinion leaders 
were recruited, trained, and returned to their communities to educate their colleagues. In 
a sense, providers who are affiliated with an academic medical center or with a 
professional group are constantly surrounded by “opinion leaders,” such as the 
departmental chairperson or leaders of a local AAP chapter. Once a consensus is reached 
among a clinical department or professional society, it is common for providers affiliated 
with these organizations to adopt the practices endorsed by the group leaders. While the 
decision is ultimately up to the individual provider, in some sense the decision of whether 
to adopt or not to adopt a new clinical practice is made by the leaders of the group at 
large. This form of education is not available to some community providers who are not 
part of a larger group, such as an academic department or professional society. They 
have to reach their decisions on their own without the benefit of having “opinion 
leaders.” While this is merely speculation, it would be interesting to further investigate 
the utility and effect of opinion leaders on changing the practices of community 
providers. 
The top sources of vaccination information identified by providers included peer 
reviewed publications, MEDLINE, educational materials from pharmaceutical 
manufacturers, and recommendations from advisory committees. Other studies have 
identified additional primary sources that providers prefer for vaccination-related 
information, such as the AAP policy statement17and the “Red Book.”18 While we 
identified an association between AAP members and adoption of the sequential schedule, 
AAP policy statements and bulletins were not commonly identified as important sources 
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for vaccination information. In our study, the use of the “Red Book” and of MEDLINE 
were associated with switching to the sequential schedule. Given that the “Red Book” is 
a reference published by the AAP and provided free to its members, the association of 
increased adoption/planned adoption of the sequential schedule with use of the “Red 
Book” mirrors the association of increased adoption with AAP membership. The 
association of MEDLINE with increased adoption does not have as straightforward a 
relationship. Perhaps through the use of MEDLINE these providers were able to stay 
best informed of new information and to learn about the complex issues regarding VAPP 
and the polio vaccination recommendations. Conversely, perhaps those who are better 
informed of medical issues choose to use MEDLINE as a source of vaccination 
information. 
Several studies have demonstrated high rates of usage of MEDLINE by health 
care professionals.19,20 When providers were asked why they preferred MEDLINE over 
other sources of information they stated that MEDLINE offered current and specific 
information, it was of low cost, and it was convenient.19 In our study, while there was no 
significant association of MEDLINE usage and AAP membership, MEDLINE users were 
more likely to have had faculty appointments and active teaching duty than non-users. It 
is possible that those with faculty appointments have increased access to computers and 
Internet services, thus explaining the association in our study of these providers and their 
use of MEDLINE. However, further research is necessary to determine whether the 
availability of these resources or the self-education practices of these physicians is most 
important in determining how providers keep abreast of changes in immunization policy. 
All providers identified similar factors that influenced their decision on which 
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schedule to adopt. Medical issues, personal judgment, and parental concerns were more 
commonly cited by all providers than legal issues, logistic issues, and cost. This is in 
contrast to a study of providers in Ohio, which found that cost and liability were 
21 significantly related to providers’ choices regarding which schedule they followed. 
Almost all providers in our study, including those who were not planning to adopt the 
sequential schedules, indicated that compliance with ACIP recommendations was 
important in making their decision regarding which schedule to adopt. While ACIP 
preferred the sequential schedule, it allowed physicians to make their own choice among 
the three vaccination schedules. The recommendations did not require a switch to one 
particular schedule in order to meet current standards of care. Thus, if a provider was 
unsure about switching schedules, he or she would have little impetus to make a switch 
given the way the recommendation was presented. If in fact complying with ACIP is an 
important factor when providers choose vaccination schedules, a strong recommendation 
by ACIP could be an important way to affect vaccination practices. It will be interesting 
to see whether the switch-over rate after January 1, 2000 to the all elPV schedule is 
adopted more readily than previous recommendations since the new recommendations do 
not allow the providers any options regarding alternate schedules. 
Other studies have shown an association between physicians’ personal 
experiences with a particular disease and their adoption of new vaccination practices. 
Physicians who had first-hand experience with complications caused by varicella virus17 
or Haemophilus influenzae type b were more likely to have adopted vaccination 
practices to protect against these diseases. For example, pediatricians who had seen a 
death from varicella were far more likely to have recommended universal immunization 

16 
as compared with those who had not seen such a devastating outcome of this disease.17 
However, complications from the polio vaccine such as VAPP are exceedingly rare and 
thus we cannot rely on physicians’ personal experience to impact on their decision to 
adopt an elPV schedule. 
Providers who had already adopted or were planning to adopt the sequential 
schedule indicated the importance of reducing the risk of VAPP more often than of 
complying with ACIP recommendations as the most important factor in choosing a 
schedule. This pattern has been demonstrated in other studies as well, where compliance 
with ACEP is not considered as important as medical issues when providers decide 
whether or not to adopt new vaccination practices.17 One can deduce that most providers 
do not readily comply with ACEP without considering the medical implications of new 
vaccination practices. 
At the time of our study, we identified two groups of providers who were still 
using an all-OPV schedule: providers who had decided to switch schedules but had not 
done so yet and those who had no plans to switch schedules. While both cohorts of 
providers identified similar factors that would make them switch schedules, there was a 
significant difference between the two groups in the importance ascribed to the 
availability of a combination vaccine. Providers who had plans to adopt the sequential 
schedule but had not done so yet indicated that the availability of an elPV-containing 
combination vaccine to decrease the number of injections per visit was a key factor that 
would motivate them to switch schedules. Several studies have investigated this finding 
of negative reactions of health professionals towards the number of injections required 
for routine vaccinations. These studies demonstrate the strong concerns of 
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physicians, ’ often greater than those of parents, about children receiving more than 3 
injections per visit. ’ A study by Mary Lou Thoms et al. demonstrated that 61.3% of 
parents would chose to have their child receive elPV and three injections per visit as 
compared with an all-OPV schedule in order to reduce the risk of VAPP. Although it 
had been a concern that adding more injections per visit could have an adverse effect of 
decreasing vaccination rates, this has not occurred for polio vaccination coverage with 
the sequential efPV-OPV schedule.15 It is important to stress to providers that additional 
injections are not regarded so negatively by parents as long as they feel that such practice 
benefits the health of their children. Given the importance that providers ascribe to 
reducing the number of injections per visit, the development and availability of 
combination vaccines would be another way to avoid this barrier that is associated with 
new vaccination practices requiring additional injections. 
A large number of providers who had no plans to adopt the sequential schedule 
indicated that a mandate from the Department of Health requiring a change in schedules 
would be the only impetus for them to change their current practice. The importance of a 
Department of Health mandate for these providers, who were less likely to be AAP 
members or to have faculty appointments than providers who had plans to switch 
schedules or those who had already done so, can be interpreted in light of the “opinion 
leader” hypothesis presented above. The Department of Health is a respected and trusted 
institution in the community to which providers look for guidance and instruction on 
current health practices and standards of care. Much like a departmental chairperson or 
AAP president who act as authorities or opinion leaders for providers affiliated with these 
organizations, the Department of Health acts as the authority for providers in the 
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community. Providers look to the Department of Health when making practice decisions 
regarding controversial issues, such as adoption of the sequential polio vaccination 
schedule. Although this is only speculation, the importance of this response is 
noteworthy in that these providers have identified an agency, beyond ACIP and other 
professional groups, which has the potential to influence providers’ choices and to 
increase compliance for vaccination programs and schedules. Increased cooperation 
between ACIP and the Department of Health along with more active involvement on the 
part of the Department of Health in promoting vaccination recommendations could have 
the potential to increase providers’ compliance with new recommendations. 
Limitations of the study: One major limitation of our study was that we did not 
directly question providers who had no plans to switch schedules about their perceived 
barriers to adoption of the sequential schedule. Our questions focused more on which 
factors were important when choosing the schedule that they currently used and less on 
which factors were important when deciding not to switch to the sequential schedule. 
Using our line of questioning, we were still able to gather some information about this, 
for instance that cost and legal issues were not important when deciding on a schedule. 
However, we cannot comment on the specific factors that kept them from switching 
schedules. 
Summary and conclusion: Although the number of providers surveyed in our 
study was small, this group of 58 accounted for the majority of the physicians providing 
care to children in Northern Manhattan. Within this group, 36% of the providers had no 
plans to switch to the sequential schedule. While all the providers in our study indicated 
familiarity with the recommendations, preferred similar sources for vaccination 
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information, and shared similar demographic characteristics, providers who had no plans 
to switch schedules were less likely to be affiliated with an academic institution or to be 
members of the AAP. Our study identified a group of providers that would benefit from 
more direct targeting to increase compliance with new vaccination practices. First, we 
encourage ACIP and other committees to continue to extend their informational effort to 
community providers who are not affiliated with either an academic institution or a 
professional group such as the AAP. The circulation of vaccination recommendations in 
a wide range of publications, such as the ones identified in our study, ensures adequate 
exposure of new recommendations to a large segment of providers. Secondly, increased 
cooperation of the Department of Health with ACIP could be one potential way to 
encourage a change in vaccination practices for many of these providers who may look to 
the Department of Health for guidance regarding such changes. 
We also offer the following recommendations to increase overall compliance with 
new vaccination recommendations among all providers in general. Given the 
importance providers ascribe to complying with ACIP, providers may be more likely to 
change their vaccination practices if ACIP introduces strong recommendations regarding 
a specific schedule to follow. In the case of the sequential schedule, there appeared to be 
less of an impetus to change schedules to an ACIP-preferred one when all three met 
current standards of care and compliance with ACIP. While compliance with ACIP was 
identified as an important factor when deciding on which schedule to use, the most 
important factor concerned the risk of VAPP. Medical issues such as VAPP should 
continue to be stressed when recommendations regarding new practices are introduced. 
Providers are not as likely to blindly follow ACIP recommendations if they do not 
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believe that they are medically important. Finally, providers’ reluctance to increase the 
number of injections per visit is a barrier to new vaccination practices that involve 
additional injections. As mentioned above, there are several ways to get around this 
barrier, such as increasing the availability of combination vaccines and providing data 
from studies that show that parents are not as averse to additional injections as providers 
may believe. 
The providers identified in our study serve a chronically under-immunized 
segment of the pediatric population that by virtue of their close contact with immigrants 
and visitors from countries where wild polio virus is still circulating, are at highest risk to 
be infected if not adequately immunized, hi a community where vaccination rates of 
children are not 100%, a switch by some providers to an all-elPV schedule, with its lack 
of circulation of live virus vaccine from immunized to unimmunized children, will raise 
the risk even further of possibly acquiring wild poliovirus. A primary goal for the future 
is to ensure adequate vaccination for all children living in these communities. One way 
to do this is to increase providers’ compliance with advisory recommendations in general. 
Therefore the identification of sources of information used by providers and the factors 
which motivate them to make choices regarding vaccination practices are critically 
important. Continued research along these lines will help further to elucidate these 
factors, to disseminate information more efficiently, and to increase compliance with 
important vaccination recommendations. 
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Table 1: Characteristics of Providers (N=58) 
Age (mean) 50 years 
Sex 
Men 71 % 
Women 29% 
Country of origin 
Dominican Republic 41 % 
Other Latin American countries 24% 
Asian countries 20% 
United States 15 % 
Training 
Graduate of non-US medical school 83% 
Completed pediatric residency training 85 % 
Completed a fellowship 45% 
Board-certified 65 % 
Years of post-graduate training (mean) 4.2 years 
Medical center affiliation 
Any faculty appointment 63 % 
Active teaching duty 26% 
Member of American Academy of Pediatrics 53 % 
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Foreign bom 83.8 % 95.2 % 0.26 (0.03-2.31) 0.198 
Graduate of non- 
US medical 
school 
78.4 % 81.0% 0.85 (0.22-3.26) 0.816 
Board-certified 70.3 % 57.1 % 1.77 (0.58-5.41) 0.312 
Completed 
fellowship 





64.9 % 33.3 % 3.69(1.19-11.44) 0.021* 
Any faculty 
appointment 
75.7 % 42.9 % 4.15 (1.32-13.04) 0.012* 
Active teaching 
duty 




Table 3: Top Information Sources Preferred by Physicians for Vaccination 
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56.8 % 57.1 % 0.98 (0.33-2.90) 0.977 
Red Book 51.4% 23.8 % 3.38 (1.02-11.14) 0.041* 





















66.7 % 45.2 % 2.43 (0.84-7.07) 0.100 
Any faculty 
appointment 






























97.3 % 100.0% + 0.447 
Medical issues 78.4 % 76.2 % 1.13 (0.32-4.05) 0.848 
Personal 
judgment 
78.4 % 71.0% 1.45 (0.42-4.95) 0.552 
Parental concerns 62.2 % 76.2 % 0.51 (0.15-1.71) 0.274 
Legal issues 54.1 % 52.4 % 1.07 (0.37-3.13) 0.902 
Logistic issues 24.3 % 23.8 % 1.03 (0.29-3.61) 0.965 
Cost 18.9% 23.8 % 0.75 (0.20-2.74) 0.659 





















Decrease risk of 
VAPP 




14.3 % 34.8 % 0.31 (0.06-1.76) 0.173 
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Table 7: Factors Cited As Motivating Change in Providers’ Practices by Adoption 


















30.4 % 14.3 % 2.63 (0.58-11.90) 0.202 
Legal mandate by 
New York City 
Department of 
Health 





17.4% 0% + 0.045* 
Evidence that 
elPV is more 
effective than 
OPV 










1 Centers for Disease Control and Prevention. 1997. Poliomyelitis prevention in the 
United States: introduction of a sequential vaccination schedule of inactivated poliovirus 
vaccine followed by oral poliovirus vaccine. Mor. Mortal. Wkly. Rep. 46: 1-25. 
2 Greco, P.J., and Eisenberg, J.M. 1993. Changing physicians’ practices. N. Engl. J. 
Med. 329:1271-1274. 
3 Cabana, M.D., Rand, C.S., Powe, N.R., Wu, A.W., Wilson, M.H., et al. 1999. Why 
don’t physicians follow clinical practice guidelines? A framework for improvement. 
JAMA. 282:1458-1465. 
4 Strebel, P.M., Sutter, R.W., Cochi, S.L., et al. 1992. Epidemiology of poliomyelitis in 
the United States one decade after the last reported case of indigenous wild virus- 
associated disease. Clin. Infect. Dis. 14:568-579. 
5 Centers for Disease Control and Prevention. 1986. Poliomyelitis-United States, 1975- 
1984. Mor. Mortal. Wkly. Rep. 35:180-182. 
6 Centers for Disease Control and Prevention. 1994. Certification of poliomyelitis 
elimination-the Americas, 1994. Mor. Mortal. Wkly. Rep. 43:720-722. 
7 World Health Assembly. 1988. Global eradication of poliomyelitis by the year 2000. 
Geneva: World Health Organization; resolution WHA 41.28. 
8 Hull, H.F., Ward, N.A., Hull, B.P., Milstein, J.B., and de Quadros, C. 1994. Paralytic 
poliomyelitis: seasoned strategies, disappearing disease. Lancet. 343:1331-1337. 
9 Centers for Disease Control and Prevention. 1999. Progress toward global 
poliomyelitis eradication-1997-1998. Mor. Mortal. Wkly. Rep. 48:416-421. 
10 Centers for Disease Control and Prevention. 1998. Vaccination coverage by 
race/ethnicity and poverty level among children aged 19-35 months-United States, 1997. 
Mor. Mortal. Wkly. Rep. 47:956-959. 
11 Onorato, I.M., Modlin, J.F., McBean, A.M., Thoms, M.L., Lasonsky, G.A., et al. 
1991. Mucosal immunity induced by enhanced-potency inactivated and oral polio 
vaccines. J. Infect. Dis. 163:1-6. 
12* 
Finn, A., and Bel, F. 1998. Polio vaccine: is it time for a change? Arch. Dis. Child. 
78:571-573. 
13 Centers for Disease Control and Prevention. 1997. Paralytic poliomyelitis: United 
States, 1980-1994. Mor. Mortal. Wkly. Rep. 46:79-83. 
t) 
29 
14 Prevots, D.R., and Strebel, P.M. 1997. Poliomyelitis prevention in the United States: 
new recommendations for routine childhood vaccination place greater reliance on 
inactivated poliovirus vaccine. Pedicitr. Ann. 26:378-383. 
15 Centers for Disease Control and Prevention. 1998. Impact of sequential IPV/OPV 
schedule on vaccination coverage levels-United States, 1997. Mor. Mortal. Wkly. Rep. 
47:1017-1019. 
16 Centers for Disease Control and Prevention. 1999. Notice to readers: 
recommendations of the Advisory Committee on Immunization Practices: revised 
recommendations for routine poliomyelitis vaccination. Mor. Mortal. Wkly. Rep. 
48:590. 
17 Newman, R.D., and Taylor, J.A. 1998. Reactions of pediatricians to the 
recommendation for universal varicella vaccination. Arch. Pediatr. Adolesc. Med. 
152:792-796. 
1 R 
Zimmerman, R.K., Schlesselman, J.J., Bard, A.L., et al. 1997. A national survey to 
understand why physicians limit childhood immunization. Arch. Pediatr. Adolesc. Med. 
151:657-664. * 
19 Lindberg, D.A., Siegel, E.R., Rapp, B.A., Wallingford, K.T., and Wilson, S.R. 1993. 
Use of MEDLINE by physicians for clinical problem solving. JAMA. 269:3124-3129. 
20 Wallingford, K.T., Humphreys, B.L., Selinger, N.E., and Siegel, E.R. 1990. 
Bibliographic retrieval: a survey of individual users of MEDLINE. MD Comput. 7:166- 
171. 
21 Kimmel, S.R., Puczynski, S., McCoy, R.C., and Puczynski., M.S. 1999. Practices of 
family physicians and pediatricians in administering poliovirus vaccine. J. Fam. Pract. 
48:594-600. 
22 Cochi, S.L., Fleming, D.W., Hull, H.F., Preblund, S.R., and Orenstein, W.A. 1986. 
Haemophilus influenzae b polysaccharide vaccine: physician acceptance and use of a 
new vaccine. Am. J. Dis. Child. 140:1226-1230. 
23 Askew, G.L., Finelli, L., Lutz, J. DeGraaf, J., Siegel, B., et al. 1995. Beliefs and 
practices regarding childhood vaccination among urban pediatric providers in New 
Jersey. Pediatrics. 96:889-892. 
24 Freed, G.L., Bordley, W.C., Clark, S.J., and Konrad, T.R. 1994. Universal hepatitis B 




25 Woodlin, K.A., Rodewald, L.E., Humiston, S.G., Carges, M.S., Schaffer, S.G., et al. 
1995. Physician and parent opinions: are children becoming pincushions from 
immunizations? Arch. Pediatr. Adolesc. Med. 149:845-849. 
Halperin, B.A., Eastwood, B.J., and Halperin S.A. 1998. Comparison of parental and 
health care professional preferences for the acellular or whole cell pertussis vaccine. 
Pediatr. Infect. Dis. J. 17:103-109. 
27 Thoms, M.L., Bodnar, P.Z., O’Donovan, J., Crossan, J., Gouel, E., et al. 1997. 
Parental knowledge and choice regarding live and inactivated poliovirus vaccines. Arch. 





HARVEY CUSHING / JOHN HAY WHITNEY 
MEDICAL LIBRARY 
MANUSCRIPT THESES 
Unpublished theses submitted for the Master's and Doctor's degrees and 
deposited in the Medical Library are to be used only with due regard to the 
rights of the authors. Bibliographical references may be noted, but passages 
must not be copied without permission of the authors, and without proper credit 
being given in subsequent written or published work. 
This thesis by has been 
used by the following persons, whose signatures attest their acceptance of the 
above restrictions. 
NAME AND ADDRESS DATE 
VALE MEDICAL LIBRARY 
3 9002 0 107 1298 

